KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CDTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Cidara Therapeutics stock price on Thursday which ended trading at $13.00
(Updated on Apr 25, 2024)

Buy candidate since Apr 25, 2024 PDF

The Cidara Therapeutics stock price gained 5.78% on the last trading day (Thursday, 25th Apr 2024), rising from $12.29 to $13.00. During the last trading day the stock fluctuated 23.30% from a day low at $12.13 to a day high of $14.96. The price has fallen in 7 of the last 10 days but is still up by 1404.46% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 693 thousand more shares were traded than the day before. In total, 751 thousand shares were bought and sold for approximately $9.76 million.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $2.90, a level that may pose a second chance to hit a runner.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CDTX Signals & Forecast

Mostly positive signals in the chart today. The Cidara Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.06 and $1.47. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, April 23, 2024, and so far it has risen 2,436.59%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Cidara Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $12.29. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.83 between high and low, or 23.30%. For the last week, the stock has had daily average volatility of 20.38%.

The Cidara Therapeutics stock is extremely overbought on RSI14 (95). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $12.60 (-3.10%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 95 and this increases the risk substantially. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (CDTX) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Cidara Therapeutics to open at $13.36, and during the day (based on 14 day Average True Range), to move between $11.90 and $14.10, which gives a possible trading interval of +/-$1.10 (+/-8.42%) up or down from last closing price. If Cidara Therapeutics takes out the full calculated possible swing range there will be an estimated 16.85% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $12.29, some $0.710 (5.46%) from the current price of $13.00, our system finds the risk reward attractive.

Is Cidara Therapeutics stock A Buy?

Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rate of rising. We conclude that the current level may hold a buying opportunity as there is a fair chance for Cidara Therapeutics stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Buy candidate.

Current score: 7.994 Strong Buy Candidate Upgraded

Predicted Opening Price for Cidara Therapeutics of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$13.36 ( 2.80%) $13.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CDTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.19 24.55 %
R2 15.11 16.24 %
R1 14.44 11.11 %
Current price: 13.00
Support S1 12.28 -5.50 %
S2 11.62 -10.64 %
S3 10.54 -18.94 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 13.00
Support S1 12.29 -5.46%
S2 0 .
S3 0 .

FAQ

What is the symbol for Cidara Therapeutics Stock and on which exchange is it traded?
The symbol for Cidara Therapeutics is CDTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cidara Therapeutics Stock?
Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rate of rising. We conclude that the current level may hold a buying opportunity as there is a fair chance for Cidara Therapeutics stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Buy candidate.

How to buy Cidara Therapeutics Stock?
Cidara Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cidara Therapeutics Stock.

What's the current price of Cidara Therapeutics Stock?
As of the end of day on the Apr 25, 2024, the price of an Cidara Therapeutics (CDTX) share was $13.00.

What is the 52-week high and low for Cidara Therapeutics Stock?
The 52-week high for Cidara Therapeutics Stock is $14.96 and the 52-week low is $0.500.

What is the market capitalization of Cidara Therapeutics Stock?
As of the Apr 25, 2024, the market capitalization of Cidara Therapeutics is 49.459M.

When is the next earnings date for Cidara Therapeutics?
The upcoming earnings date for Cidara Therapeutics is May 09, 2024.
Click to get the best stock tips daily for free!

About Cidara Therapeutics

Cidara Therapeutics Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive... CDTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT